During the past decade, Connecticut Clinical Research Foundation conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 23 clinical trials were completed, i.e. on average, 69.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 18 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Connecticut Clinical Research Foundation" #1 sponsor was "Celgene" with 8 trials, followed by "Pfizer" with 5 trials sponsored, "Shire" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connecticut Clinical Research Foundation" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Connecticut Clinical Research Foundation" are "Ulcerative Colitis" (9 trials), "Crohn Disease" (5 trials), "Crohn's Disease" (3 trials), "Eosinophilic Esophagitis" (3 trials) and "Eosinophilic Esophagitis (EoE)" (3 trials). Many other conditions were trialed in "Connecticut Clinical Research Foundation" in a lesser frequency.

Most popular intervention types in "Connecticut Clinical Research Foundation" are "Drug" (35 trials), "Other" (5 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Filgotinib" (4 trials), "Ozanimod" (3 trials), "Vonoprazan" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Connecticut Clinical Research Foundation" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Connecticut Clinical Research Foundation". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Connecticut Clinical Research Foundation, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Clinical Research Foundation, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Connecticut Clinical Research Foundation has several departments that took part in Clinical trials: "Connecticut Gastroenterology Institute" - 13 trials